Newsfeeds - Spark Newswire

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

Today, 5:08 PM

Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.

AQB

1 minute read

BrainStorm Presents New Biomarker Analyses From NurOwn’s Phase 3 ALS Trial At The ALS ONE Research Symposium

By Benzinga Newsdesk

Today, 5:08 PM

NurOwn® drove biomarker responses, affecting pathways related to neurodegeneration, neuroinflammation, and neuroprotection, that were consistent in participants with both advanced ALS and less advanced disease,

BCLI

4 minute read

Penny Stocks

BCLI: Filing a BLA for NurOwn® for the Treatment of ALS…

By Zacks Small Cap Research

Today, 5:08 PM

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT

BCLI

1 minute read

BrainStorm To File US Application For NurOwn In Amyotrophic Lateral Sclerosis

By Vandana Singh

Today, 5:08 PM

BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) announced its decision to submit a marketing application to the FDA seeking approval for NurOwn for…

BCLI

9 minute read

Earnings

Earnings Scheduled For August 15, 2022

By Benzinga Insights

Today, 5:08 PM

Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

ABOS

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 5:08 PM

Gainers

BCLI

4 minute read

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 5:08 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ABT

3 minute read

The Daily Biotech Pulse: Third FDA Rejection For Verrica’s Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva’s Chikungunya Vaccine

By Vandana Singh

Today, 5:08 PM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ASMB

1 minute read

Recap: Brainstorm Cell Q1 Earnings

By Benzinga Insights

Today, 5:08 PM

Brainstorm Cell (NASDAQ:BCLI) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

BCLI

10 minute read

Earnings Scheduled For May 16, 2022

By Benzinga Insights

Today, 5:08 PM

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

ACRX